The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.
Silver - Firms: litigation
Recommended - Firms: transactions
Gold - Firms: prosecution
“Bereskin & Parr is the type of firm you can entrust with absolutely anything – it will always deliver excellent quality and added value to its clients, while keeping costs reasonable. The team is extremely responsive to client needs and innovative in suggesting effective strategies. Unsurprisingly, it is at the top of any list for IP representation in Canada.” Leading the litigation group is Andrew McIntosh, whose chemistry background and smooth advocacy skills make him well suited to technically intricate disputes. Lately, he has been defending Nova Chemicals alongside Robert MacFarlane and Adam Bobker in a claim for the disgorgement of its profits relating to a patent infringement suit brought by Dow Chemical Corporation. Courtroom supremo MacFarlane has been stacking up the wins for more than 40 years; Bobker is “a bright lawyer who thinks on his feet and provides clear guidance in disputes and smart strategies in injunction proceedings”. The pair recently linked up with IAM Patent 1000 debutant Joshua Spicer to represent Packers Plus Energy Services in infringement actions for damages and accounting of profits. Spicer is acclaimed as “an excellent litigator who strikes a balance between what is required from a business standpoint and ensuring patent rights are identified and protected to the full extent of the law. His advocacy, work ethic and attention to detail are exceptional”. Coming through for GlaxoSmithKline are Donald Cameron, Scott MacKendrick and Melanie Szweras, who have been meticulously handling two proceedings against Sandoz and Gilead relating to its HIV medication. Cameron is a trusted ally of innovators in the courtroom, having served as senior trial counsel in Canada’s first-ever DNA patent trial; and the esteemed MacKendrick is likewise at home when acting in hefty disputes. Versatile multi-tasker Melanie Szweras combines litigation and prosecution capabilities to provide detailed guidance that considers the entire patent lifecycle. Also new to the guide this year and bolstering the firm’s prosecution offering are Carmela DeLuca and Jason Hynes. A co-founder of the Greater Montreal Chapter of Women in Bio, DeLuca advises start-ups and universities on biotechnology and pharmaceutical applications, as well as plant breeders’ rights. Those who have collaborated with Hynes have nothing but good things to say: “Jason’s technical knowledge and ability to quickly understand inventions are fantastic. From the beginning, he made it clear that he was there to do the heavy lifting and make the process as painless as possible.” Life sciences division spearhead and co-leader of the cannabis practice Micheline Gravelle is not afraid to stray off the beaten path in search of innovative solutions to protecting patents. She is key counsel to Autolus Therapeutics and has seen through many of its applications relating to the use of CAR-T cells in the treatment of cancer. Similarly, Patricia Folkins relishes working with emerging technologies and has recently been filing for OICIR in relation to its first-in-class pre-clinical therapeutic targeting the WDR5 protein for the treatment of blood cancers. She speaks the language of inventors thanks to time spent in-house at a leading biopharmaceutical company. On the mechanical side, Philip Mendes da Costa and Robert Storey are the names to note. When it comes to the strategic development of patent portfolios, Mendes da Costa is the go-to; while Storey has cultivated deep reserves of knowledge over his 40 years of practice and is a font of wisdom for a high-flying clientele. The firm’s patent offering is completed by a razor-sharp transactional practice, which is home to Bhupinder Randhawa, Victor Krichker and Noel Courage. Electrical and computer technology group leader Randhawa knows how to locate critical IP rights and monetise them to maximum effect. An authority on technology, Kirchker is a safe pair of hands for software licences; while Courage is the resident medical inventions connoisseur, who counts the University Health Network among his clients.